0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Antibody Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-10C14754
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Antibody Service Market Research Report 2023
BUY CHAPTERS

Global Recombinant Antibody Service Market Research Report 2025

Code: QYRE-Auto-10C14754
Report
May 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Antibody Service Market

The global market for Recombinant Antibody Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Recombinant Antibody Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Antibody Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Antibody Service in Biopharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Antibody Service include GenScript Biotech Corporation, Abcam plc, Creative Biolabs, Absolute Antibody Ltd., Thermo Fisher Scientific Inc., ProteoGenix, Bio-Rad Laboratories, Inc., Rockland Immunochemicals Inc., RayBiotech, Inc., Novoprotein Scientific Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Antibody Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Antibody Service.
The Recombinant Antibody Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Antibody Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Antibody Service Market Report

Report Metric Details
Report Name Recombinant Antibody Service Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript Biotech Corporation, Abcam plc, Creative Biolabs, Absolute Antibody Ltd., Thermo Fisher Scientific Inc., ProteoGenix, Bio-Rad Laboratories, Inc., Rockland Immunochemicals Inc., RayBiotech, Inc., Novoprotein Scientific Inc., Sino Biological Inc., Abnova Corporation, ACROBiosystems, Fitzgerald Industries International, Boster Biological Technology Co., Ltd., HyTest Ltd., Randox Laboratories Ltd., Agilent Technologies, Inc., AnaSpec, Inc., Epitomics International Inc., Cell Signaling Technology, Inc., OriGene Technologies, Inc., Meridian Life Science Inc., Enzo Life Sciences, Inc., MabPlex Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant Antibody Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Antibody Service Market report?

Ans: The main players in the Recombinant Antibody Service Market are GenScript Biotech Corporation, Abcam plc, Creative Biolabs, Absolute Antibody Ltd., Thermo Fisher Scientific Inc., ProteoGenix, Bio-Rad Laboratories, Inc., Rockland Immunochemicals Inc., RayBiotech, Inc., Novoprotein Scientific Inc., Sino Biological Inc., Abnova Corporation, ACROBiosystems, Fitzgerald Industries International, Boster Biological Technology Co., Ltd., HyTest Ltd., Randox Laboratories Ltd., Agilent Technologies, Inc., AnaSpec, Inc., Epitomics International Inc., Cell Signaling Technology, Inc., OriGene Technologies, Inc., Meridian Life Science Inc., Enzo Life Sciences, Inc., MabPlex Inc.

What are the Application segmentation covered in the Recombinant Antibody Service Market report?

Ans: The Applications covered in the Recombinant Antibody Service Market report are Biopharmaceuticals, Diagnostics, Research, Therapeutics

What are the Type segmentation covered in the Recombinant Antibody Service Market report?

Ans: The Types covered in the Recombinant Antibody Service Market report are Antibody Generation, Optimization, Engineering, Modification, Expression

Recommended Reports

Antibody Services

Recombinant Proteins

Biopharma Contracting

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Generation
1.2.3 Optimization
1.2.4 Engineering
1.2.5 Modification
1.2.6 Expression
1.3 Market by Application
1.3.1 Global Recombinant Antibody Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceuticals
1.3.3 Diagnostics
1.3.4 Research
1.3.5 Therapeutics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Service Market Perspective (2020-2031)
2.2 Global Recombinant Antibody Service Growth Trends by Region
2.2.1 Global Recombinant Antibody Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Antibody Service Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Antibody Service Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Antibody Service Market Dynamics
2.3.1 Recombinant Antibody Service Industry Trends
2.3.2 Recombinant Antibody Service Market Drivers
2.3.3 Recombinant Antibody Service Market Challenges
2.3.4 Recombinant Antibody Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Service Players by Revenue
3.1.1 Global Top Recombinant Antibody Service Players by Revenue (2020-2025)
3.1.2 Global Recombinant Antibody Service Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant Antibody Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Antibody Service Revenue
3.4 Global Recombinant Antibody Service Market Concentration Ratio
3.4.1 Global Recombinant Antibody Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Service Revenue in 2024
3.5 Global Key Players of Recombinant Antibody Service Head office and Area Served
3.6 Global Key Players of Recombinant Antibody Service, Product and Application
3.7 Global Key Players of Recombinant Antibody Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Service Breakdown Data by Type
4.1 Global Recombinant Antibody Service Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Antibody Service Forecasted Market Size by Type (2026-2031)
5 Recombinant Antibody Service Breakdown Data by Application
5.1 Global Recombinant Antibody Service Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Antibody Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Antibody Service Market Size (2020-2031)
6.2 North America Recombinant Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Antibody Service Market Size by Country (2020-2025)
6.4 North America Recombinant Antibody Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Service Market Size (2020-2031)
7.2 Europe Recombinant Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Antibody Service Market Size by Country (2020-2025)
7.4 Europe Recombinant Antibody Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Service Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Antibody Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Antibody Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Antibody Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Service Market Size (2020-2031)
9.2 Latin America Recombinant Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Antibody Service Market Size by Country (2020-2025)
9.4 Latin America Recombinant Antibody Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Service Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Antibody Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Antibody Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Antibody Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Details
11.1.2 GenScript Biotech Corporation Business Overview
11.1.3 GenScript Biotech Corporation Recombinant Antibody Service Introduction
11.1.4 GenScript Biotech Corporation Revenue in Recombinant Antibody Service Business (2020-2025)
11.1.5 GenScript Biotech Corporation Recent Development
11.2 Abcam plc
11.2.1 Abcam plc Company Details
11.2.2 Abcam plc Business Overview
11.2.3 Abcam plc Recombinant Antibody Service Introduction
11.2.4 Abcam plc Revenue in Recombinant Antibody Service Business (2020-2025)
11.2.5 Abcam plc Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Recombinant Antibody Service Introduction
11.3.4 Creative Biolabs Revenue in Recombinant Antibody Service Business (2020-2025)
11.3.5 Creative Biolabs Recent Development
11.4 Absolute Antibody Ltd.
11.4.1 Absolute Antibody Ltd. Company Details
11.4.2 Absolute Antibody Ltd. Business Overview
11.4.3 Absolute Antibody Ltd. Recombinant Antibody Service Introduction
11.4.4 Absolute Antibody Ltd. Revenue in Recombinant Antibody Service Business (2020-2025)
11.4.5 Absolute Antibody Ltd. Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Details
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Recombinant Antibody Service Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.5.5 Thermo Fisher Scientific Inc. Recent Development
11.6 ProteoGenix
11.6.1 ProteoGenix Company Details
11.6.2 ProteoGenix Business Overview
11.6.3 ProteoGenix Recombinant Antibody Service Introduction
11.6.4 ProteoGenix Revenue in Recombinant Antibody Service Business (2020-2025)
11.6.5 ProteoGenix Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Antibody Service Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Rockland Immunochemicals Inc.
11.8.1 Rockland Immunochemicals Inc. Company Details
11.8.2 Rockland Immunochemicals Inc. Business Overview
11.8.3 Rockland Immunochemicals Inc. Recombinant Antibody Service Introduction
11.8.4 Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.8.5 Rockland Immunochemicals Inc. Recent Development
11.9 RayBiotech, Inc.
11.9.1 RayBiotech, Inc. Company Details
11.9.2 RayBiotech, Inc. Business Overview
11.9.3 RayBiotech, Inc. Recombinant Antibody Service Introduction
11.9.4 RayBiotech, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.9.5 RayBiotech, Inc. Recent Development
11.10 Novoprotein Scientific Inc.
11.10.1 Novoprotein Scientific Inc. Company Details
11.10.2 Novoprotein Scientific Inc. Business Overview
11.10.3 Novoprotein Scientific Inc. Recombinant Antibody Service Introduction
11.10.4 Novoprotein Scientific Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.10.5 Novoprotein Scientific Inc. Recent Development
11.11 Sino Biological Inc.
11.11.1 Sino Biological Inc. Company Details
11.11.2 Sino Biological Inc. Business Overview
11.11.3 Sino Biological Inc. Recombinant Antibody Service Introduction
11.11.4 Sino Biological Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.11.5 Sino Biological Inc. Recent Development
11.12 Abnova Corporation
11.12.1 Abnova Corporation Company Details
11.12.2 Abnova Corporation Business Overview
11.12.3 Abnova Corporation Recombinant Antibody Service Introduction
11.12.4 Abnova Corporation Revenue in Recombinant Antibody Service Business (2020-2025)
11.12.5 Abnova Corporation Recent Development
11.13 ACROBiosystems
11.13.1 ACROBiosystems Company Details
11.13.2 ACROBiosystems Business Overview
11.13.3 ACROBiosystems Recombinant Antibody Service Introduction
11.13.4 ACROBiosystems Revenue in Recombinant Antibody Service Business (2020-2025)
11.13.5 ACROBiosystems Recent Development
11.14 Fitzgerald Industries International
11.14.1 Fitzgerald Industries International Company Details
11.14.2 Fitzgerald Industries International Business Overview
11.14.3 Fitzgerald Industries International Recombinant Antibody Service Introduction
11.14.4 Fitzgerald Industries International Revenue in Recombinant Antibody Service Business (2020-2025)
11.14.5 Fitzgerald Industries International Recent Development
11.15 Boster Biological Technology Co., Ltd.
11.15.1 Boster Biological Technology Co., Ltd. Company Details
11.15.2 Boster Biological Technology Co., Ltd. Business Overview
11.15.3 Boster Biological Technology Co., Ltd. Recombinant Antibody Service Introduction
11.15.4 Boster Biological Technology Co., Ltd. Revenue in Recombinant Antibody Service Business (2020-2025)
11.15.5 Boster Biological Technology Co., Ltd. Recent Development
11.16 HyTest Ltd.
11.16.1 HyTest Ltd. Company Details
11.16.2 HyTest Ltd. Business Overview
11.16.3 HyTest Ltd. Recombinant Antibody Service Introduction
11.16.4 HyTest Ltd. Revenue in Recombinant Antibody Service Business (2020-2025)
11.16.5 HyTest Ltd. Recent Development
11.17 Randox Laboratories Ltd.
11.17.1 Randox Laboratories Ltd. Company Details
11.17.2 Randox Laboratories Ltd. Business Overview
11.17.3 Randox Laboratories Ltd. Recombinant Antibody Service Introduction
11.17.4 Randox Laboratories Ltd. Revenue in Recombinant Antibody Service Business (2020-2025)
11.17.5 Randox Laboratories Ltd. Recent Development
11.18 Agilent Technologies, Inc.
11.18.1 Agilent Technologies, Inc. Company Details
11.18.2 Agilent Technologies, Inc. Business Overview
11.18.3 Agilent Technologies, Inc. Recombinant Antibody Service Introduction
11.18.4 Agilent Technologies, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.18.5 Agilent Technologies, Inc. Recent Development
11.19 AnaSpec, Inc.
11.19.1 AnaSpec, Inc. Company Details
11.19.2 AnaSpec, Inc. Business Overview
11.19.3 AnaSpec, Inc. Recombinant Antibody Service Introduction
11.19.4 AnaSpec, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.19.5 AnaSpec, Inc. Recent Development
11.20 Epitomics International Inc.
11.20.1 Epitomics International Inc. Company Details
11.20.2 Epitomics International Inc. Business Overview
11.20.3 Epitomics International Inc. Recombinant Antibody Service Introduction
11.20.4 Epitomics International Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.20.5 Epitomics International Inc. Recent Development
11.21 Cell Signaling Technology, Inc.
11.21.1 Cell Signaling Technology, Inc. Company Details
11.21.2 Cell Signaling Technology, Inc. Business Overview
11.21.3 Cell Signaling Technology, Inc. Recombinant Antibody Service Introduction
11.21.4 Cell Signaling Technology, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.21.5 Cell Signaling Technology, Inc. Recent Development
11.22 OriGene Technologies, Inc.
11.22.1 OriGene Technologies, Inc. Company Details
11.22.2 OriGene Technologies, Inc. Business Overview
11.22.3 OriGene Technologies, Inc. Recombinant Antibody Service Introduction
11.22.4 OriGene Technologies, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.22.5 OriGene Technologies, Inc. Recent Development
11.23 Meridian Life Science Inc.
11.23.1 Meridian Life Science Inc. Company Details
11.23.2 Meridian Life Science Inc. Business Overview
11.23.3 Meridian Life Science Inc. Recombinant Antibody Service Introduction
11.23.4 Meridian Life Science Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.23.5 Meridian Life Science Inc. Recent Development
11.24 Enzo Life Sciences, Inc.
11.24.1 Enzo Life Sciences, Inc. Company Details
11.24.2 Enzo Life Sciences, Inc. Business Overview
11.24.3 Enzo Life Sciences, Inc. Recombinant Antibody Service Introduction
11.24.4 Enzo Life Sciences, Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.24.5 Enzo Life Sciences, Inc. Recent Development
11.25 MabPlex Inc.
11.25.1 MabPlex Inc. Company Details
11.25.2 MabPlex Inc. Business Overview
11.25.3 MabPlex Inc. Recombinant Antibody Service Introduction
11.25.4 MabPlex Inc. Revenue in Recombinant Antibody Service Business (2020-2025)
11.25.5 MabPlex Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Recombinant Antibody Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibody Generation
 Table 3. Key Players of Optimization
 Table 4. Key Players of Engineering
 Table 5. Key Players of Modification
 Table 6. Key Players of Expression
 Table 7. Global Recombinant Antibody Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Recombinant Antibody Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Recombinant Antibody Service Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Recombinant Antibody Service Market Share by Region (2020-2025)
 Table 11. Global Recombinant Antibody Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Recombinant Antibody Service Market Share by Region (2026-2031)
 Table 13. Recombinant Antibody Service Market Trends
 Table 14. Recombinant Antibody Service Market Drivers
 Table 15. Recombinant Antibody Service Market Challenges
 Table 16. Recombinant Antibody Service Market Restraints
 Table 17. Global Recombinant Antibody Service Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Recombinant Antibody Service Market Share by Players (2020-2025)
 Table 19. Global Top Recombinant Antibody Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Service as of 2024)
 Table 20. Ranking of Global Top Recombinant Antibody Service Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Recombinant Antibody Service Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Recombinant Antibody Service, Headquarters and Area Served
 Table 23. Global Key Players of Recombinant Antibody Service, Product and Application
 Table 24. Global Key Players of Recombinant Antibody Service, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Recombinant Antibody Service Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Recombinant Antibody Service Revenue Market Share by Type (2020-2025)
 Table 28. Global Recombinant Antibody Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Recombinant Antibody Service Revenue Market Share by Type (2026-2031)
 Table 30. Global Recombinant Antibody Service Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Recombinant Antibody Service Revenue Market Share by Application (2020-2025)
 Table 32. Global Recombinant Antibody Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Recombinant Antibody Service Revenue Market Share by Application (2026-2031)
 Table 34. North America Recombinant Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Recombinant Antibody Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Recombinant Antibody Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Recombinant Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Recombinant Antibody Service Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Recombinant Antibody Service Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Recombinant Antibody Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Recombinant Antibody Service Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Recombinant Antibody Service Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Recombinant Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Recombinant Antibody Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Recombinant Antibody Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Recombinant Antibody Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Recombinant Antibody Service Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Recombinant Antibody Service Market Size by Country (2026-2031) & (US$ Million)
 Table 49. GenScript Biotech Corporation Company Details
 Table 50. GenScript Biotech Corporation Business Overview
 Table 51. GenScript Biotech Corporation Recombinant Antibody Service Product
 Table 52. GenScript Biotech Corporation Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 53. GenScript Biotech Corporation Recent Development
 Table 54. Abcam plc Company Details
 Table 55. Abcam plc Business Overview
 Table 56. Abcam plc Recombinant Antibody Service Product
 Table 57. Abcam plc Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 58. Abcam plc Recent Development
 Table 59. Creative Biolabs Company Details
 Table 60. Creative Biolabs Business Overview
 Table 61. Creative Biolabs Recombinant Antibody Service Product
 Table 62. Creative Biolabs Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 63. Creative Biolabs Recent Development
 Table 64. Absolute Antibody Ltd. Company Details
 Table 65. Absolute Antibody Ltd. Business Overview
 Table 66. Absolute Antibody Ltd. Recombinant Antibody Service Product
 Table 67. Absolute Antibody Ltd. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 68. Absolute Antibody Ltd. Recent Development
 Table 69. Thermo Fisher Scientific Inc. Company Details
 Table 70. Thermo Fisher Scientific Inc. Business Overview
 Table 71. Thermo Fisher Scientific Inc. Recombinant Antibody Service Product
 Table 72. Thermo Fisher Scientific Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 73. Thermo Fisher Scientific Inc. Recent Development
 Table 74. ProteoGenix Company Details
 Table 75. ProteoGenix Business Overview
 Table 76. ProteoGenix Recombinant Antibody Service Product
 Table 77. ProteoGenix Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 78. ProteoGenix Recent Development
 Table 79. Bio-Rad Laboratories, Inc. Company Details
 Table 80. Bio-Rad Laboratories, Inc. Business Overview
 Table 81. Bio-Rad Laboratories, Inc. Recombinant Antibody Service Product
 Table 82. Bio-Rad Laboratories, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 83. Bio-Rad Laboratories, Inc. Recent Development
 Table 84. Rockland Immunochemicals Inc. Company Details
 Table 85. Rockland Immunochemicals Inc. Business Overview
 Table 86. Rockland Immunochemicals Inc. Recombinant Antibody Service Product
 Table 87. Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 88. Rockland Immunochemicals Inc. Recent Development
 Table 89. RayBiotech, Inc. Company Details
 Table 90. RayBiotech, Inc. Business Overview
 Table 91. RayBiotech, Inc. Recombinant Antibody Service Product
 Table 92. RayBiotech, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 93. RayBiotech, Inc. Recent Development
 Table 94. Novoprotein Scientific Inc. Company Details
 Table 95. Novoprotein Scientific Inc. Business Overview
 Table 96. Novoprotein Scientific Inc. Recombinant Antibody Service Product
 Table 97. Novoprotein Scientific Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 98. Novoprotein Scientific Inc. Recent Development
 Table 99. Sino Biological Inc. Company Details
 Table 100. Sino Biological Inc. Business Overview
 Table 101. Sino Biological Inc. Recombinant Antibody Service Product
 Table 102. Sino Biological Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 103. Sino Biological Inc. Recent Development
 Table 104. Abnova Corporation Company Details
 Table 105. Abnova Corporation Business Overview
 Table 106. Abnova Corporation Recombinant Antibody Service Product
 Table 107. Abnova Corporation Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 108. Abnova Corporation Recent Development
 Table 109. ACROBiosystems Company Details
 Table 110. ACROBiosystems Business Overview
 Table 111. ACROBiosystems Recombinant Antibody Service Product
 Table 112. ACROBiosystems Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 113. ACROBiosystems Recent Development
 Table 114. Fitzgerald Industries International Company Details
 Table 115. Fitzgerald Industries International Business Overview
 Table 116. Fitzgerald Industries International Recombinant Antibody Service Product
 Table 117. Fitzgerald Industries International Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 118. Fitzgerald Industries International Recent Development
 Table 119. Boster Biological Technology Co., Ltd. Company Details
 Table 120. Boster Biological Technology Co., Ltd. Business Overview
 Table 121. Boster Biological Technology Co., Ltd. Recombinant Antibody Service Product
 Table 122. Boster Biological Technology Co., Ltd. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 123. Boster Biological Technology Co., Ltd. Recent Development
 Table 124. HyTest Ltd. Company Details
 Table 125. HyTest Ltd. Business Overview
 Table 126. HyTest Ltd. Recombinant Antibody Service Product
 Table 127. HyTest Ltd. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 128. HyTest Ltd. Recent Development
 Table 129. Randox Laboratories Ltd. Company Details
 Table 130. Randox Laboratories Ltd. Business Overview
 Table 131. Randox Laboratories Ltd. Recombinant Antibody Service Product
 Table 132. Randox Laboratories Ltd. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 133. Randox Laboratories Ltd. Recent Development
 Table 134. Agilent Technologies, Inc. Company Details
 Table 135. Agilent Technologies, Inc. Business Overview
 Table 136. Agilent Technologies, Inc. Recombinant Antibody Service Product
 Table 137. Agilent Technologies, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 138. Agilent Technologies, Inc. Recent Development
 Table 139. AnaSpec, Inc. Company Details
 Table 140. AnaSpec, Inc. Business Overview
 Table 141. AnaSpec, Inc. Recombinant Antibody Service Product
 Table 142. AnaSpec, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 143. AnaSpec, Inc. Recent Development
 Table 144. Epitomics International Inc. Company Details
 Table 145. Epitomics International Inc. Business Overview
 Table 146. Epitomics International Inc. Recombinant Antibody Service Product
 Table 147. Epitomics International Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 148. Epitomics International Inc. Recent Development
 Table 149. Cell Signaling Technology, Inc. Company Details
 Table 150. Cell Signaling Technology, Inc. Business Overview
 Table 151. Cell Signaling Technology, Inc. Recombinant Antibody Service Product
 Table 152. Cell Signaling Technology, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 153. Cell Signaling Technology, Inc. Recent Development
 Table 154. OriGene Technologies, Inc. Company Details
 Table 155. OriGene Technologies, Inc. Business Overview
 Table 156. OriGene Technologies, Inc. Recombinant Antibody Service Product
 Table 157. OriGene Technologies, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 158. OriGene Technologies, Inc. Recent Development
 Table 159. Meridian Life Science Inc. Company Details
 Table 160. Meridian Life Science Inc. Business Overview
 Table 161. Meridian Life Science Inc. Recombinant Antibody Service Product
 Table 162. Meridian Life Science Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 163. Meridian Life Science Inc. Recent Development
 Table 164. Enzo Life Sciences, Inc. Company Details
 Table 165. Enzo Life Sciences, Inc. Business Overview
 Table 166. Enzo Life Sciences, Inc. Recombinant Antibody Service Product
 Table 167. Enzo Life Sciences, Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 168. Enzo Life Sciences, Inc. Recent Development
 Table 169. MabPlex Inc. Company Details
 Table 170. MabPlex Inc. Business Overview
 Table 171. MabPlex Inc. Recombinant Antibody Service Product
 Table 172. MabPlex Inc. Revenue in Recombinant Antibody Service Business (2020-2025) & (US$ Million)
 Table 173. MabPlex Inc. Recent Development
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources
 Table 177. Authors List of This Report


List of Figures
 Figure 1. Recombinant Antibody Service Picture
 Figure 2. Global Recombinant Antibody Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Antibody Service Market Share by Type: 2024 VS 2031
 Figure 4. Antibody Generation Features
 Figure 5. Optimization Features
 Figure 6. Engineering Features
 Figure 7. Modification Features
 Figure 8. Expression Features
 Figure 9. Global Recombinant Antibody Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Recombinant Antibody Service Market Share by Application: 2024 VS 2031
 Figure 11. Biopharmaceuticals Case Studies
 Figure 12. Diagnostics Case Studies
 Figure 13. Research Case Studies
 Figure 14. Therapeutics Case Studies
 Figure 15. Recombinant Antibody Service Report Years Considered
 Figure 16. Global Recombinant Antibody Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Recombinant Antibody Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Recombinant Antibody Service Market Share by Region: 2024 VS 2031
 Figure 19. Global Recombinant Antibody Service Market Share by Players in 2024
 Figure 20. Global Top Recombinant Antibody Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Service as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Recombinant Antibody Service Revenue in 2024
 Figure 22. North America Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Recombinant Antibody Service Market Share by Country (2020-2031)
 Figure 24. United States Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Recombinant Antibody Service Market Share by Country (2020-2031)
 Figure 28. Germany Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Recombinant Antibody Service Market Share by Region (2020-2031)
 Figure 36. China Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Antibody Service Market Share by Country (2020-2031)
 Figure 44. Mexico Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Recombinant Antibody Service Market Share by Country (2020-2031)
 Figure 48. Turkey Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Recombinant Antibody Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 52. Abcam plc Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 53. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 54. Absolute Antibody Ltd. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 55. Thermo Fisher Scientific Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 56. ProteoGenix Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 57. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 58. Rockland Immunochemicals Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 59. RayBiotech, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 60. Novoprotein Scientific Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 61. Sino Biological Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 62. Abnova Corporation Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 63. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 64. Fitzgerald Industries International Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 65. Boster Biological Technology Co., Ltd. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 66. HyTest Ltd. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 67. Randox Laboratories Ltd. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 68. Agilent Technologies, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 69. AnaSpec, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 70. Epitomics International Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 71. Cell Signaling Technology, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 72. OriGene Technologies, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 73. Meridian Life Science Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 74. Enzo Life Sciences, Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 75. MabPlex Inc. Revenue Growth Rate in Recombinant Antibody Service Business (2020-2025)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart